{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:56:09Z","timestamp":1761562569667,"version":"3.44.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009663","name":"University Health Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jtcvsonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.jtcvs.2019.10.122","type":"journal-article","created":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T11:27:33Z","timestamp":1573644453000},"page":"2082-2091.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Prognostic influence of tumor microenvironment after hypofractionated radiation and surgery for mesothelioma"],"prefix":"10.1016","volume":"159","author":[{"given":"Marc","family":"de Perrot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Licun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Cabanero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Yannis","family":"Perentes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trevor D.","family":"McKee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Donahoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Penelope","family":"Bradbury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikihiro","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Lin","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaf","family":"Keshavjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Sound","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. C. John","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtcvs.2019.10.122_bib1","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S1470-2045(17)30446-1","article-title":"Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial","volume":"18","author":"Maio","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtcvs.2019.10.122_bib2","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.jtho.2018.08.2024","article-title":"Treat it or leave it: immuno-oncology in mesothelioma observed by the eyes of Argus","volume":"13","author":"de Gooijer","year":"2018","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtcvs.2019.10.122_bib3","doi-asserted-by":"crossref","first-page":"e98575","DOI":"10.1172\/jci.insight.98575","article-title":"Comprehensive immunoproteogenomic analyses of malignant pleural mesothelioma","volume":"3","author":"Lee","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.jtcvs.2019.10.122_bib4","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1158\/2326-6066.CIR-16-0171","article-title":"Cytotoxic T cells in PD-L1-positive malignant pleural mesotheliomas are counterbalanced by distinct immunosuppressive factors","volume":"4","author":"Awad","year":"2016","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.jtcvs.2019.10.122_bib5","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jtcvs.2007.10.026","article-title":"Impact of tumor-infiltrating T cells on survival in patients with malignant pleural mesothelioma","volume":"135","author":"Anraku","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2019.10.122_bib6","doi-asserted-by":"crossref","first-page":"e1009285","DOI":"10.1080\/2162402X.2015.1009285","article-title":"The\u00a0tumoral\u00a0and stromal immune microenvironment in malignant pleural mesothelioma: a\u00a0comprehensive analysis reveals prognostic immune markers","volume":"4","author":"Ujiie","year":"2015","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jtcvs.2019.10.122_bib7","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.jtho.2017.02.013","article-title":"The immune microenvironment, genome-wide copy number aberrations, and survival in mesothelioma","volume":"12","author":"Thapa","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtcvs.2019.10.122_bib8","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1093\/annonc\/mdy086","article-title":"Malignant pleural\u00a0mesothelioma immune microenvironment and checkpoint expression: correlation with clinical-pathological features and intratumor heterogeneity over time","volume":"29","author":"Pasello","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtcvs.2019.10.122_bib9","doi-asserted-by":"crossref","first-page":"5502","DOI":"10.1158\/1078-0432.CCR-17-0438","article-title":"In situ vaccination after accelerated hypofractionated radiation and surgery in a mesothelioma mouse model","volume":"23","author":"De La Maza","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtcvs.2019.10.122_bib10","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1038\/s41591-018-0232-2","article-title":"Radiotherapy induces responses of lung cancer to CTLA-4 blockade","volume":"24","author":"Formenti","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.jtcvs.2019.10.122_bib11","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/JTO.0000000000000078","article-title":"A feasibility study evaluating Surgery for Mesothelioma After Radiation Therapy: the \u201cSMART\u201d approach for resectable malignant pleural mesothelioma","volume":"9","author":"Cho","year":"2014","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtcvs.2019.10.122_bib12","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jtcvs.2015.09.129","article-title":"Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma","volume":"151","author":"de Perrot","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2019.10.122_bib13","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1111\/apt.15250","article-title":"Evaluation of optimal biopsy location for assessment of histological activity, transcriptomic and immunohistochemical analyses in patients with active Crohn's disease","volume":"49","author":"Novak","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jtcvs.2019.10.122_bib14","doi-asserted-by":"crossref","first-page":"1601428","DOI":"10.1183\/13993003.01428-2016","article-title":"Impact of tumour thickness on survival after radical radiation and surgery in malignant pleural mesothelioma","volume":"49","author":"de Perrot","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jtcvs.2019.10.122_bib15","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/bjc.2017.269","article-title":"Evaluating the effect of immune cells on the outcome of patients with mesothelioma","volume":"117","author":"Chee","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jtcvs.2019.10.122_bib16","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1158\/1078-0432.CCR-16-2848","article-title":"Tumor-infiltrating and peripheral blood T-cell immunophenotypes predict early relapse in localized clear cell renal cell carcinoma","volume":"23","author":"Giraldo","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtcvs.2019.10.122_bib17","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.it.2018.06.001","article-title":"Immunological mechanisms responsible for radiation-induced abscopal effect","volume":"39","author":"Rodr\u00edguez-Ruiz","year":"2018","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jtcvs.2019.10.122_bib18","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/eji.201546113","article-title":"Human plasmacytoid dentritic cells elicit a Type I interferon response by sensing\u00a0DNA via the cGAS-STING signaling pathway","volume":"46","author":"Bode","year":"2016","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jtcvs.2019.10.122_bib19","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.4049\/jimmunol.1500447","article-title":"NK Cells preferentially target tumor cells with a cancer stem cell phenotype","volume":"195","author":"Ames","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.jtcvs.2019.10.122_bib20","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/CJI.0b013e3182a801f2","article-title":"Antitumor impact of interferon-\u03b3 producing CD1d-restricted NKT cells in murine malignant mesothelioma","volume":"36","author":"Tagawa","year":"2013","journal-title":"J Immunother"},{"key":"10.1016\/j.jtcvs.2019.10.122_bib21","doi-asserted-by":"crossref","first-page":"E89","DOI":"10.3390\/ijms19010089","article-title":"The dark side of IFN-\u03b3: its role in promoting cancer immunoevasion","volume":"19","author":"Mojic","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtcvs.2019.10.122_bib22","doi-asserted-by":"crossref","first-page":"200ra116","DOI":"10.1126\/scitranslmed.3006504","article-title":"Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells","volume":"5","author":"Spranger","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jtcvs.2019.10.122_bib23","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1038\/modpathol.2017.59","article-title":"PD-L1 immunohistochemistry in clinical diagnostics of lung cancer: inter-pathologist variability is higher than assay variability","volume":"30","author":"Brunnstr\u00f6m","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jtcvs.2019.10.122_bib24","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.celrep.2017.04.031","article-title":"Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression","volume":"19","author":"Garcia-Diaz","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.jtcvs.2019.10.122_bib25","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1158\/0008-5472.CAN-18-2207","article-title":"IFN\u03b3-Induced IFIT5 promotes epithelial-to-mesenchymal transition in prostate cancer via miRNA processing","volume":"79","author":"Lo","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.jtcvs.2019.10.122_bib26","doi-asserted-by":"crossref","first-page":"5874","DOI":"10.4049\/jimmunol.1202612","article-title":"Radiation-induced equilibrium is a balance between tumor cell proliferation and T cell-mediated killing","volume":"190","author":"Liang","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.jtcvs.2019.10.122_bib27","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3389\/fonc.2018.00386","article-title":"Tumor-intrinsic PD-L1 signaling in cancer initiation, development and treatment: beyond immune evasion","volume":"8","author":"Dong","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.jtcvs.2019.10.122_bib28","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1158\/2159-8290.CD-18-0804","article-title":"Integrative molecular characterization of malignant pleural mesothelioma","volume":"8","author":"Hmeljak","year":"2018","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jtcvs.2019.10.122_bib29","doi-asserted-by":"crossref","first-page":"15618","DOI":"10.1038\/ncomms15618","article-title":"DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity","volume":"8","author":"Vanpouille-Box","year":"2017","journal-title":"Nat Commun"}],"container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522319325140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522319325140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T17:06:46Z","timestamp":1758388006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022522319325140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0022522319325140"],"URL":"https:\/\/doi.org\/10.1016\/j.jtcvs.2019.10.122","relation":{},"ISSN":["0022-5223"],"issn-type":[{"type":"print","value":"0022-5223"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic influence of tumor microenvironment after hypofractionated radiation and surgery for mesothelioma","name":"articletitle","label":"Article Title"},{"value":"The Journal of Thoracic and Cardiovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtcvs.2019.10.122","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by The American Association for Thoracic Surgery","name":"copyright","label":"Copyright"}]}}